BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19945477)

  • 1. A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.
    Gigliucci V; Buckley KN; Nunan J; O'Shea K; Harkin A
    Pharmacol Biochem Behav; 2010 Feb; 94(4):524-33. PubMed ID: 19945477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.
    Dias Elpo Zomkowski A; Oscar Rosa A; Lin J; Santos AR; Calixto JB; Lúcia Severo Rodrigues A
    Brain Res; 2004 Oct; 1023(2):253-63. PubMed ID: 15374751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H; Wang W; Jiang Z; Shang J; Zhang L
    Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test.
    Kaster MP; Santos AR; Rodrigues AL
    Brain Res Bull; 2005 Sep; 67(1-2):53-61. PubMed ID: 16140163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP; Bouvard M; Stinus L
    Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test.
    Ulak G; Mutlu O; Tanyeri P; Komsuoglu FI; Akar FY; Erden BF
    Pharmacol Biochem Behav; 2010 May; 95(3):308-14. PubMed ID: 20171242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional specific modulation of neuronal activation associated with nitric oxide synthase inhibitors in an animal model of antidepressant activity.
    Sherwin E; Gigliucci V; Harkin A
    Behav Brain Res; 2017 Jan; 316():18-28. PubMed ID: 27569181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test.
    Harkin A; Connor TJ; Burns MP; Kelly JP
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):274-81. PubMed ID: 15163436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine.
    Stenfors C; Ross SB
    Life Sci; 2002 Nov; 71(24):2867-2880. PubMed ID: 12377268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain.
    Karolewicz B; Paul IA; Antkiewicz-Michaluk L
    Pol J Pharmacol; 2001; 53(6):587-96. PubMed ID: 11985332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors.
    Harkin A; Connor TJ; Walsh M; St John N; Kelly JP
    Neuropharmacology; 2003 Apr; 44(5):616-23. PubMed ID: 12668047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.
    Rénéric JP; Bouvard M; Stinus L
    Eur Neuropsychopharmacol; 2002 Apr; 12(2):159-71. PubMed ID: 11872334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nitric oxide-cGMP pathway in selegiline antidepressant-like effect in the mice forced swim test.
    Ostadhadi S; Shakiba S; Norouzi-Javidan A; Nikoui V; Zolfaghari S; Chamanara M; Dehpour AR
    Pharmacol Rep; 2018 Oct; 70(5):1015-1022. PubMed ID: 30144662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems.
    Brocardo PS; Budni J; Kaster MP; Santos AR; Rodrigues AL
    Neuropharmacology; 2008 Feb; 54(2):464-73. PubMed ID: 18078962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat.
    Kirby LG; Lucki I
    J Pharmacol Exp Ther; 1997 Aug; 282(2):967-76. PubMed ID: 9262365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.